Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.61 |
| ▸ | PLA2G4B | P0C869 | 7/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 6/20 | 0.56 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28874771 | 0.98 | LTA4H (0.59) | LTA4HPLA2G4BTSHRRECQLFAAH | |
| N-Amyl Phenoxyacetate SCHEMBL8673101 | 0.95 | LTA4H (0.60) | LTA4HPLA2G4BTSHRFAAHPLA2G4A | |
| SCHEMBL28304205 | 0.94 | PLA2G4B (0.60) | LTA4HPLA2G4BTSHRFAAHPLA2G4A | |
| SCHEMBL21384549 | 0.94 | PLA2G4B (0.60) | LTA4HPLA2G4BTSHRFAAHPLA2G4A | |
| SCHEMBL27690411 | 0.94 | PLA2G4B (0.60) | LTA4HPLA2G4BTSHRFAAHPLA2G4A | |
| SCHEMBL3156982 | 0.94 | PLA2G4B (0.60) | LTA4HPLA2G4BTSHRFAAHPLA2G4A | |
| SCHEMBL9627007 | 0.94 | PLA2G4B (0.60) | LTA4HPLA2G4BTSHRFAAHPLA2G4A | |
| SCHEMBL21381323 | 0.94 | PLA2G4B (0.60) | LTA4HPLA2G4BTSHRFAAHPLA2G4A | |
| SCHEMBL570689 | 0.94 | PLA2G4B (0.60) | LTA4HPLA2G4BTSHRFAAHPLA2G4A | |
| N-Amyl Phenoxyacetate SCHEMBL28169747 | 0.94 | LTA4H (0.58) | LTA4HPLA2G4BTSHRFAAHPLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115725035-A | Slump-retaining concrete superplasticizer, preparation method and application thereof | 博特新材料泰州有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-106134994-A | A kind of artificial cultivation method of radix ranunculi ternati | 无锡南理工科技发展有限公司 | 2016-11-23 | — | — | CN | claimed |
| CN-117645540-A | Preparation method of chlorophenoxycarboxylate | 山东润博生物科技有限公司 | 2024-03-05 | — | — | CN | disclosed |
| CN-115725035-A | Slump-retaining concrete superplasticizer, preparation method and application thereof | 博特新材料泰州有限公司 | 2023-03-03 | — | — | CN | disclosed |
| CN-115594588-A | Preparation method of phenoxyacetic acid ester | 山东潍坊润丰化工股份有限公司（CN） | 2023-01-13 | — | — | CN | disclosed |
| US-11078150-B2 | Preparation method for chlorophenoxycarboxylate | SHANDONG RAINBOW BIOTECH CO., LTD. (CN) | 2021-08-03 | — | — | US | disclosed |
| US-20210002201-A1 | PREPARATION METHOD FOR CHLOROPHENOXYCARBOXYLATE | SHANDONG RAINBOW BIOTECH CO., LTD. (CN) | 2021-01-07 | — | — | US | disclosed |
| CN-109628541-B | Method for synthesizing penicillin V salt by enzyme method | 湖南福来格生物技术有限公司 | 2020-03-17 | — | — | CN | disclosed |
| EP-2869389-B1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION CELL USING SAME | MITSUBISHI CHEM CORP (JP) | 2019-11-13 | — | — | EP | disclosed |
| WO-2019179291-A2 | PREPARATION METHOD FOR CHLOROPHENOXYCARBOXYLATE | 山东润博生物科技有限公司 | 2019-09-26 | — | — | WO | disclosed |
| WO-2019179288-A2 | PREPARATION METHOD FOR CHLOROPHENOXYCARBOXYLATE | 山东润博生物科技有限公司 | 2019-09-26 | — | — | WO | disclosed |
| CN-107033470-A | A kind of control cable for nuclear power station | 安徽省无为县经纬电缆附件有限公司 | 2017-08-11 | — | — | CN | disclosed |
| CN-106414741-A | Use of 2-chloro-3- (methylsulfanyl) -N- (1-methyl-1H-tetrazol-5-yl) -4- (trifluoromethyl) benzamide or a salt thereof for controlling unwanted vegetation in areas of transgenic crop plants tolerant to HPPD inhibitor herbicides | 拜耳作物科学股份公司 | 2017-02-15 | — | — | CN | disclosed |
| CN-105837563-A | Production method of flumioxazin | 四川义结科技有限责任公司 | 2016-08-10 | — | — | CN | disclosed |
| US-20150140448-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-05-21 | — | — | US | disclosed |
| EP-2869389-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION CELL USING SAME | Mitsubishi Chemical Corporation (JP) | 2015-05-06 | — | — | EP | disclosed |
| US-7563917-B2 | Silicon compound and a production process for silicon compound | CHISSO CORPORATION (JP) | 2009-07-21 | — | — | US | disclosed |
| US-20070004932-A1 | Silicon compound and a production process for silicon compound | JNC CORPORATION (JP) | 2007-01-04 | — | — | US | disclosed |
| US-4071579-A | Novel peresters suitable for initiating the polymerization or copolymerization of ethylenically unsaturated compounds | AKZONA INCORPORATED (US) | 1978-01-31 | — | — | US | disclosed |
| US-4016187-A | USEFUL IN POLYMERIZATION AS INITIATORS | AKZONA INCORPORATED (US) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210002201-A1 | PREPARATION METHOD FOR CHLOROPHENOXYCARBOXYLATE | CBLB, CBL, CBLC | LTA4H 2857/4885PLA2G4B 1307/4885TSHR 1177/4885 |
| US-11078150-B2 | Preparation method for chlorophenoxycarboxylate | CBLB, CBL, CBLC | LTA4H 2857/4885PLA2G4B 1307/4885TSHR 1177/4885 |
| US-20070004932-A1 | Silicon compound and a production process for silicon compound | STS, SMS, SRM | LTA4H 692/4885PLA2G4B 2949/4885TSHR 1330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.